GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allegra Medical Technologies Ltd (ASX:AMT) » Definitions » 6-1 Month Momentum %

Allegra Medical Technologies (ASX:AMT) 6-1 Month Momentum % : -29.27% (As of May. 17, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Allegra Medical Technologies 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-17), Allegra Medical Technologies's 6-1 Month Momentum % is -29.27%.

The industry rank for Allegra Medical Technologies's 6-1 Month Momentum % or its related term are showing as below:

ASX:AMT's 6-1 Month Momentum % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -8.005 vs ASX:AMT: -29.27

Competitive Comparison of Allegra Medical Technologies's 6-1 Month Momentum %

For the Medical Devices subindustry, Allegra Medical Technologies's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allegra Medical Technologies's 6-1 Month Momentum % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allegra Medical Technologies's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Allegra Medical Technologies's 6-1 Month Momentum % falls into.



Allegra Medical Technologies  (ASX:AMT) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allegra Medical Technologies  (ASX:AMT) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Allegra Medical Technologies 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Allegra Medical Technologies's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Allegra Medical Technologies (ASX:AMT) Business Description

Traded in Other Exchanges
N/A
Address
18-20 Orion Road, Level 8, Lane Cove West, Sydney, NSW, AUS, 2066
Allegra Medical Technologies Ltd is engaged in the research, product development, and manufacturing of medical devices including prosthetic implant tools. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip stems and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems among others. It operates in two segments Orthopaedics Division, which derives the majority of its revenue sells and distributes its portfolio of medical device products. Innovation Division which invests resources into the development and commercialization of new products to take to market.